Alana Hippensteele, Editor

Articles

Positive Results for the Treatment of Advanced Cervical Cancer

May 18, 2021

A phase 3 trial investigating the PD-1 inhibitor cemiplimab in patients with recurrent or metastatic cervical cancer who had previously progressed on chemotherapy showed a significant improvement in overall survival.